Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2025 Sep 10.
Published in final edited form as: Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 Sep 10;10(8):833–845. doi: 10.1016/j.bpsc.2024.09.001

Multivariate Association between Functional Connectivity Gradients and Cognition in Schizophrenia Spectrum Disorders

Ju-Chi Yu 1, Colin Hawco 1,2, Lucy Bassman 1, Lindsay D Oliver 1,2, Miklos Argyelan 3, James M Gold 4, Sunny X Tang 3, George Foussias 1,2, Robert W Buchanan 4, Anil K Malhotra 3, Stephanie H Ameis 1,2, Aristotle N Voineskos 1,2,*, Erin W Dickie 1,2,*
PMCID: PMC11891086  NIHMSID: NIHMS2023467  PMID: 39260567

Abstract

Background:

Schizophrenia Spectrum Disorders (SSDs), which are characterized by social cognitive deficits, have been associated with dysconnectivity in “unimodal” (e.g., visual, auditory) and “multimodal” (e.g., default-mode and frontoparietal) cortical networks. However, little is known regarding how such dysconnectivity relates to social and non-social cognition, and how such brain-behavioral relationships associate with clinical outcomes of SSDs.

Methods:

We analyzed cognitive (non-social and social) measures and resting-state functional magnetic resonance imaging data from the ‘Social Processes Initiative in Neurobiology of the Schizophrenia(s) (SPINS)’ study (247 stable participants with SSDs and 172 healthy controls, ages 18–55). We extracted gradients from parcellated connectomes and examined the association between the first 3 gradients and the cognitive measures using partial least squares correlation (PLSC). We then correlated the PLSC dimensions with functioning and symptoms in the SSDs group.

Results:

The SSDs group showed significantly lower differentiation on all three gradients. The first PLSC dimension explained 68.53% (p<.001) of the covariance and showed a significant difference between SSDs and Controls (bootstrap p<.05). PLSC showed that all cognitive measures were associated with gradient scores of unimodal and multimodal networks (Gradient 1), auditory, sensorimotor, and visual networks (Gradient 2), and perceptual networks and striatum (Gradient 3), which were less differentiated in SSDs. Furthermore, the first dimension was positively correlated with negative symptoms and functioning in the SSDs group.

Conclusions:

These results suggest a potential role of lower differentiation of brain networks in cognitive and functional impairments in SSDs.

Keywords: principal gradient analysis, schizophrenia spectrum disorders, social cognition, functional connectivity, partial least squares correlation, fMRI

Introduction

Schizophrenia spectrum disorders (SSDs) are characterized by positive, negative, and general psychopathology symptoms, as well as deficits in social and non-social cognition that affect daily life. Two prior studies found consistent network segregation patterns in SSDs characterized by dysconnectivity in “unimodal” (e.g., visual, auditory) and “multimodal” (e.g., default mode, frontoparietal) cortical networks (1,2). Such changes in cortical network configuration can be explored using an emerging technique known as principal gradient analysis, which is a data reduction method used to characterize participants’ brain connectivity profiles (3). This approach provides a topographical representation of functional connectivity and network organization by extracting principal gradients (i.e., a type of latent dimension) from a participant’s brain connectivity pattern and identifying the dominant network segregation patterns from each gradient.

Human behaviors and cognitions are often generated from the coordinated functioning of different brain regions (4), which is closely linked to the geometry of brain (5). Gradient analysis provides a multivariate framework where the dimensions (i.e., the gradients) are aligned with geodesic brain features (3) and are found meaningful biologically (68), developmentally (9,10), and evolutionarily (11). These extracted gradient scores represent the organization of brain regions along hierarchical levels which map onto different levels of cognition, with higher gradient scores in opposite directions representing greater segregation of networks along the corresponding hierarchical network level. When represented by a scatter plot, the lower segregation is represented by networks having gradient scores closer to 0 on the axes resulting in a lower variance of the overall gradient scores, thus called ‘gradient compression.’ With such interpretation, gradient analysis has been used to examine how functional connectivity relates to cognition; e.g., creativity performance (12) and semantic cognition (13,14), where the neurocognitive system of semantic cognition was found also to regulate social cognition (15). By using such gradient technique to examine functional connectivity of SSDs, recent studies found that, compared to Controls, people with SSDs feature unimodal-multimodal (1,16,17) and visual-sensorimotor (1,18) gradient compressions with the unimodal-multimodal gradient compression correlating with clinical symptoms (1,17) and lower processing speed (17). As people with SSDs vary extensively in symptoms (19), treatment response (20,21), cognition (22,23), and brain activity (2426), gradient analysis provides a general principle of quantifying functional brain organization to investigate individual differences in brain configurations of SSDs while accounting for heterogeneous brain features, which relate to treatment responses (27) and psychotic symptoms (1,17,27) of people with SSDs.

Social and non-social cognition are critically important to functioning in people with SSDs (2831). Previous literature (3235), including work by our group (2,26), suggests that non-social cognitive performance, and particularly social cognitive performance, may relate to network segregation in people with SSDs. With a large sample of participants measured on social and non-social cognition, application of gradient analysis may help further our understanding of how network segregation relates to these two aspects of cognitive deficits in SSDs. As social and non-social cognition are strongly related to functional outcomes (2,27,36,37), further examination on brain gradient-cognitive relationships can reveal how such relationships influence individual differences in the functional outcomes in SSDs.

To examine brain gradient-cognitive relationships, we used data from the National Institute of Mental Health (NIMH)-funded “Social Processes Initiative in the Neurobiology of Schizophrenia(s) (SPINS)” multicenter study (37). These harmonized data included functional brain imaging and comprehensive assessments of both social and non-social cognition. To account for inter-assessment associations and maximize statistical power, we examined brain-behavior relationships with a multivariate approach, which extracts latent dimensions that identify the dominant association between large sets of variables. The individual differences within associations were then used to examine how brain-behavior relationships manifest individual differences in functioning. In addition to replicating prior findings of gradient compression in SSDs, we specifically aimed to 1) identify the gradients that are associated with social and non-social cognition, and 2) examine how such associations contribute to clinical outcomes, including functioning, quality of life, and clinical symptoms in people with SSDs.

Methods and Materials

Participants

In total, 274 participants with SSDs and 172 Controls from the SPINS study were analyzed (37). The diagnoses of SSDs (i.e., schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder, and psychotic disorder) were based on the DSM-5 as assessed by the Structured Clinical Interview for DSM (SCID-IV-TR). All participants with SSDs had no changes in antipsychotic medication or functioning/support level for 30 days before enrollment. Participants were excluded if they had a history of head trauma, substance use disorder, intellectual disability, unstable medical illness, or other neurological diseases. Controls were excluded if they had any lifetime Axis I psychiatric disorder (except adjustment disorder, phobic disorder, and past major depression with 2+ years remission and currently unmedicated) or a first-degree relative with a psychotic disorder. Chlorpromazine (CPZ) equivalents were calculated for the 222 participants with SSDs based on available medication information (38). All participants provided informed consent; the research followed the Declaration of Helsinki and was approved by relevant ethics and institutional review boards. Detailed characteristics of the SSDs group are shown in Tables S1S2.

Demographics, Cognitive, and Clinical Assessment

Premorbid IQ was estimated by the Wechsler Test of Adult Reading (WTAR) (39). Psychiatric symptoms in SSDs were evaluated using the Brief Psychiatric Rating Scale (BPRS) (40) and Scale for the Assessment of Negative Symptoms (SANS) (41,42). Functional outcomes were assessed using the Birchwood Social Functioning Scale (BSFS) (43) and Quality of Life Scale (QLS) (44).

The study collected a comprehensive battery of non-social and social cognitive measures that have previously been described in detail (37,45). Non-social cognition was assessed using the 6 domain scores of the MATRICS (Measurement and Treatment Research to Improve Cognition in Schizophrenia) Consensus Cognitive Battery (MCCB) (46): processing speed, reasoning/problem solving, attention/vigilance, working memory, verbal learning, and visual learning. The social cognitive battery included the Penn Emotion Recognition Test (ER40) (47), Reading the Mind in the Eyes Test (RMET) (48), and The Awareness of Social Inference Test – Revised (TASIT) (49), which included three sub-tests: TASIT 1, identifying emotions; TASIT 2, minimal social inferences including sincere, simple sarcasm, and paradoxical sarcasm; and TASIT 3, measuring social inferences (lies and sarcasm) with enriched contextual cues. These 14 cognitive variables (including ER40 total, RMET total, TASIT 1 total, 3 subscores from TASIT 2, 2 subscores from TASIT 3, and the 6 domain scores from MCCB) were used as cognitive data to examine associations with the principal gradients.

MRI Data Acquisition and Quality Control

Multimodal MRI scans were obtained using 3T scanners with multichannel head coils (see Supplementary Materials). Anatomical T1-weighted scans were collected using a fast-gradient sequence (0.9mm isotropic voxels, see supplemental for site specific parameters). Resting-state scan was a 7-minute EPI sequence (TR=2000 ms, TE=30 ms, flip angle=77°, field of view=20°, in-plane resolution=3.125 mm2, and slice thickness=4 mm). Participants were instructed to let their mind wander with their eyes closed (wakefulness information is included in Supplementary Materials).

All scans were quality checked before and after being preprocessed by fMRIPrep 1.5.8 (50) and ciftify 2.3.1 (51) workflows. From the preprocessing, all scans were performed nuisance regression to correct for head motion, white matter signal, cerebral spinal fluid signal, and the global signal (see details for imaging preprocessing in Supplementary Material). Participants with excessive motion (mean framewise displacement>0.5 mm) were excluded from further analysis (see Figure S1).

Connectivity Matrix Construction

To construct connectivity matrices, we parcellated the brain using the cortical Multimodal Parcellation (52) atlas (360 regions) and the Melbourne Subcortex Atlas (53) with all cortical regions categorized into twelve networks according to the Cole-Anticevic Brain Network Parcellation (54) (see Figure 1A), with the subcortical regions grouped separately. For each participant, a 392 × 392 functional connectivity matrix was created via the Fisher Z-transformation of the Pearson’s correlation of the time-series from each parcel. Finally, we used the neuroCombat R package to perform ComBat, a batch-effect correction, on the Z-transformed connectivity to harmonize the connectivity data across 6 MRI scanners (55,56).

Figure 1. Principal gradient analysis and partial least squares correlation (PLSC).

Figure 1.

A illustrates the Glasser atlas, with 360 regions categorized into 12 networks from the Cole-Anticevic Brain Network Parcellation, indicated by different colors. B and C illustrate the network segregations of the three gradients respectively in brain and in the gradient space. B shows the average gradient scores across all participants (purple for positive scores and yellow for negative scores). C shows the average gradient scores across all participants in two scatter plots, respectively for Gradients 1 vs. 2 and for Gradient 2 vs. 3. In these scatter plots, each small dot represents a brain region and is colored according to its network; the bigger opaque dots illustrate the mean gradient scores of all 12 networks. Overall, Gradient 1 features Somatosensory vs. Frontoparietal network segregation; Gradient 2 features Auditory/Motor vs. Visual network segregation; and Gradient 3 features Default mode vs. Frontoparietal network segregation. D illustrates the PLSC procedure (see more details in Supplementary Materials).

Network Hierarchy Measures: Gradient Analysis

To quantify network hierarchy, gradient analysis uses a dimension reduction approach to extract principal gradients from a brain connectivity matrix. In the procedure, the data were transformed back to Pearson correlation coefficients after ComBat, and the data for each participant underwent diffusion map embedding (57) using the BrainSpace package (58) to extract principal gradients (3), consistent with the approach shown in http://brainspace.readthedocs.io. These gradients capture specific network segregations that contribute to the overall functional connectivity pattern. Gradients are ordered such that they contribute to the total variance in a descending order. To allow comparisons between gradients across participants, we aligned them via Procrustean rotation with a template gradient map (3). The goodness of fit of each participant to the template from (3) is illustrated in Figure S2. This gradient map reveals the three gradients shown in Figures 1B1C. The ROIs are represented by scores on each gradient, and these gradient scores are averaged across brain networks to illustrate the representations of these networks on these gradients. As expected, the first gradient differentiates connectivity between the unimodal networks (e.g., primary and secondary visual (VIS1 and VIS2), auditory (AUD), and somatomotor (SMN) networks) from the multimodal networks (e.g., default mode (DMN), frontoparietal (FPN), and language (LAN) networks). The second gradient further differentiates connectivity within the unimodal networks (i.e., VIS1 and VIS2 vs. AUD and SMN), and the third gradient differentiates within the multimodal networks (i.e., DMN and LAN vs. FPN and cingular opercular network (CON)). This gradient analysis was performed with Python 3.8.6-GCCcore-10.2.0. Distributions of eigenvalues of all extracted gradients are shown in Figure S3 to illustrate the variance explained by each gradient.

Statistical Analyses

We examined group differences between participants with SSDs and Controls in demographics and cognition with two-sample t-tests (or equivalent tests to account for non-normally distributed or heterogeneous data; see Supplementary Materials). Group differences (SSDs-Control) in gradient scores were also examined with two-sample t-tests using the linear model approach (i.e., the lm function in R) and were corrected for multiple comparisons with a false discovery rate (FDR) approach (q<.05). Age, sex assigned at birth, and mean framewise displacement (FD) were regressed out from all behavior and brain measures prior to all analyses. From the linear model, we report the number (n) of significant ROIs of each network with their range of F-statistics.

Multivariate associations between the cognitive and network hierarchy measures across SSDs and Control groups were then analyzed by partial least squares correlation (PLSC) (59), relating 14 cognitive variables (8 social cognitive scores and 6 MCCB domain scores) to 1176 brain variables (gradient scores of the first 3 dimensions of 392 brain regions). In PLSC, each variable is centered (i.e., having a mean of 0) and normalized (such that the sum of squared values equals 1). PLSC then extracts, from their cross product, latent dimensions, which are analogous to components in principal component analysis (PCA), explaining associations between the brain and cognitive measures. On each dimension, PLSC generates pairs of latent variables, analogous to factor scores in PCA; consisting of one computed from the cognitive variables (i.e., cognitive scores) and one from the brain variables (i.e., brain scores), which together have maximum covariance. Significance of PLSC dimensions was assessed via permutation tests (60), while bootstrap tests (61) were used to examine the stability of the loadings for each variable. From both tests, we derived p values to indicate significant differences. Additionally, the bootstrap test gives a Z-analogous statistic called bootstrap ratio (BR), of which a value of 2.88 is associated with a p of .005. This allows the identification of variables that significantly contribute to each dimension. The effect sizes of variables were quantified by their contributions, computed as squared loadings, to determine the importance of each variable to each dimension. We further verified the PLSC model with 10-fold and 4-fold cross-validation (see Supplementary Materials).

To examine the clinical representation of PLSC results, we performed Pearson correlation tests within the SSDs sample between the brain and the cognitive scores from PLSC and all subscores of the symptom and functioning measures. Participants with missing values were removed from related analyses. Results were FDR-corrected for 8 comparisons with q<.05. All data analyses were performed using R 4.1.1 (62) with PLSC being performed using the TExPosition and the data4PCCAR packages (https://github.com/HerveAbdi/data4PCCAR).

Results

Demographics and Behavioral Characteristics

After quality control (detailed in Figure S1), the data analysis included 247 participants with SSDs (Mage=31.40, SDage=9.79, 79 females) and 172 Controls (Mage=31.95, SDage=10.40, 80 females). Participant characteristics and cognitive test scores are shown in Table 1. Two-sample t-tests showed no significant age difference between the SSDs and the Control groups. SSDs had lower mean scores than Controls for all cognitive measures except TASIT 2 sincere videos, consistent with prior findings (2,45) (See Table 1).

Table 1. Demographics and Behavioral Characteristics.

The table shows the means and standard deviations (SD) of the demographics and the clinical and behavioral characteristics of each participant group. The statistics of examining the group effects are shown in the last three columns for each variable.

SSD (n = 247) Control (n = 172)

Mean (SD) Mean (SD) df * t q(FDR)

Age (years) 31.40 (9.79) 31.95 (10.40) 353.56 −0.54 .588
Female (n; %) 79 (31.98%) 80 (46.51%)
Mean framewise displacement (FD; mm) 0.16 (0.1) 0.14 (0.08) 414 1.53 .134
Parental education level – Father (years) 14.48 (3.18) 15.40 (3.07) 186.55 −2.12 .035
Parental education level – Mother (years) 14.08 (3.06) 14.93 (2.63) 198.03 −2.16 .035
Wechsler Test of Adult Reading (WTAR) Standard Score 108.11 (14.31) 113.71 (10.81) 167 −2.67 .017
Chlorpromazine (CPZ) equivalents 463.68 (382.37) -- -- -- --
Clinical measures
Brief Psychiatric Rating Scale (BPRS) 31.33 (7.87) -- -- -- --
Scale for the Assessment of Negative Symptoms (SANS) 25.11 (12.33) -- -- -- --
Birchwood Social Functioning Scale (BSFS) 136.42 (23.18) 175.16 (19.21) -- -- < .001§
Quality of Life Scale (QLS) 73.64 (21.00) -- -- -- --
Social cognitive measures
Penn Emotion Recognition Task (ER40) 31.85 (4.55) 33.55 (3.32) 412 −4.16 < .001
Reading the Mind in the Eyes Test (RMET) 24.58 (5.26) 27.60 (3.82) 416 −6.41 < .001
TASIT 1 22.50 (3.65) 24.64 (2.14) 417 −6.90 < .001
TASIT 2 paradoxical sarcasm 15.72 (3.96) 18.52 (2.09) 417 −8.47 < .001
TASIT 2 simple sarcasm 14.88 (4.95) 18.47 (1.92) 417 −9.05 < .001
TASIT 2 sincere 16.93 (3.18) 17.48 (2.69) 4187 −1.86 .073
TASIT 3 lies 24.80 (4.11) 27.25 (3.64) 392.84 −6.41 < .001
TASIT 3 sarcasm 23.52 (5.15) 27.47 (3.62) 414 −8.65 < .001
Non-social cognitive measures (MCCB)
Processing speed 39.67 (13.19) 53.06 (10.10) -- -- < .001§
Reasoning and problem solving 42.86 (10.97) 48.76 (9.54) 396.81 −5.85 < .001
Attention/Vigilance 39.57 (11.63) 47.65 (12.72) 345.36 −6.59 < .001
Working memory 41.30 (11.20) 49.16 (11.36) -- -- < .001§
Verbal learning 40.69 (8.95) 50.30 (9.44) 355.22 −10.47 < .001
Visual learning 38.78 (12.46) 48.38 (10.06) 417 −8.38 < .001

denotes a sample that did not pass the normality test

denotes a Welch’s t

§

denotes results from a bootstrap test.

*

The degrees of freedom change between measures because of the tests being used (i.e., a t-test, a Welch’s t-test, or a bootstrap t test) and the number of missing values before the imputation.

Lower Differentiation Across all Three Gradients in SSDs vs. Controls

The significant group differences in gradients across brain regions are shown in Figure 2A and illustrated by arrows representing each region of interest (ROI) in Figures 2B2D pointing from the mean gradient scores of Controls to those of the SSDs group. Overall, participants with SSDs showed lower differentiations at FDR-corrected α=0.05 along all three gradients, indicating weaker modularity, possibly due to stronger between-network or weaker within-network connectivity on these dimensions. Specifically, on Gradient 1 (unimodal vs. multimodal), somatomotor (SMN), primary and secondary visual (VIS1 and VIS2), and default mode networks (DMN) are found to be less differentiated from auditory (AUD), cingulo-opercular (CON), frontoparietal (FPN), and subcortical (SUB) networks in participants with SSDs than in Controls, q<.05. On Gradient 2 (visual vs. auditory), the SSDs group has less differentiation of CON, SUB, SMN, AUD, and FPN from dorsal attention (DAN), VIS1, and VIS2, q<.05. On Gradient 3 (default vs. frontoparietal), the SSDs group showed lower differentiation of CON and SUB from DAN, VIS1, VIS2, and language (LAN) networks, q<.05. Detailed statistics are reported in Table 2 with ranges of significant F statistics and numbers of significant ROIs of each network. Such gradient compression is not confounded by motion, as it appears in both the top-half and the bottom-half movers (see Supplementary Materials and Figures S6S7).

Figure 2. Group differences in Gradients 1–3.

Figure 2.

A shows the brain regions with significant group differences according to two-sample t-tests (as linear models). Warm colors indicate Controls being significantly closer than SSDs to the positive ends of the gradients (i.e., the default/frontoparietal, the visual, and the frontoparietal networks, respectively); cold colors indicate Controls being significantly closer than SSDs to the negative ends of the gradients (i.e., the somatosensory/visual, the auditory/motor, and the default mode networks, respectively). BD show the brain regions with group differences along Gradients 1–3 in a 3D space; specifically, C shows the regions with a significant group difference along Gradient 2 (i.e., the x-axis of the plot), and D shows the regions with a significant group difference along Gradient 3 (i.e., the y-axis of the plot). These three figures show how each ROI moves along the three gradients from Controls to SSDs (as indicated by the arrows). Each arrow represents one ROI and is colored according to the networks defined by Cole-Anticevic (cortical) and Tian (subcortical) parcellations in Figure 1A. The network labels illustrate where the means of the networks are for Controls.

Table 2.

Significant group differences in regions of interest (ROIs) on Gradients 1–3.

Gradient 1 Gradient 2 Gradient 3

Networks F range n of ROIs F range n of ROIs F range n of ROIs

Visual1 [−4.76, −3.51] 4 [2.58, 2.9] 2 [−4.99, −4.99] 2
Visual2 [−5, −3.01] 9 [2.63, 5.54] 41 [−3.95, 5.63] 15
Somatomotor [−3.61, −2.62] 13 [−6.36, −2.69] 21 [−2.89, 3.19] 2
Cingulo-Opercular [2.58, 3.38] 12 [−6.7, −2.6] 32 [2.76, 3.29] 5
Dorsal-Attention [−3.05, −2.92] 2 [2.81, 4.85] 9 [−4.49, −2.58] 4
Language [3.65, 3.65] 1 [−2.64, −2.64] 1 [−3.99, −2.78] 7
Frontoparietal [2.76, 4.09] 4 [−4.03, −3.73] 3 -- 0
Auditory [2.7, 3.05] 6 [−5.63, −2.85] 12 [−2.96, −2.96] 1
Default Mode [−5.55, −2.9] 7 [−4.33, 4.39] 11 [2.57, 3.2] 2
Posterior-Multimodal -- 0 -- 0 [−2.92, −2.92] 1
Ventral-multimodal -- 0 0 -- 0
Orbito-Affective -- 0 [−2.69, −2.69] 1 -- 0
Subcortical [2.78, 4.79] 6 [−4.79, −2.62] 4 [2.67, 4.56] 11

The table summarizes the group effects found in all three gradients by networks and lists, for each network, the range of the significant F statistics and the number of significant ROIs.

Multivariate analysis of cognitive-network hierarchy PLSC reveals a significant dimension, whereby networks with lower differentiation relate to cognitive performance

PLSC analysis identified one significant dimension, as determined by permutation test (p<.001), explaining 68.53% of the cognition-gradient covariance. This dimension features the general correlations between all cognitive measures (both social and non-social; Figure 3A) and network hierarchy (Figure 3B). The loadings in Figure 3A show that all cognitive measures contribute similarly (i.e., in the same direction). In this dimension, participants with SSDs and Controls are significantly different according to a bootstrap test both in brain and in cognitive scores as indicated by non-overlapping 95% bootstrap confidence intervals of their means (Figure 3C).

Figure 3. The first dimension of PLSC.

Figure 3.

The loadings for the cognitive measures (A) and the network hierarchy (B) illustrate the general associations of the cognitive measures and the network hierarchy. The latent variables of Dimension 1 are shown in C where SSDs and Controls are significantly different according to bootstrap tests both according to the network hierarchy and to their cognitive measures. Together, A and B show associations that contribute to the group differences shown in C. Because this dimension is characterized by the group difference, in D-F, we highlighted such group differences (indicated by the arrows) of the identified regions of interest (ROIs) on Gradients 1 (D), 2 (E), and 3 (F). The highlighted arrows in these figures illustrate the group differences in the identified ROI gradients that most relate to cognition according to PLSC. On these figures, each arrow indicates the change from Controls to SSDs. The opaqueness of the arrows illustrates the amount of scaled contributions (i.e., squared loadings × 100), and the shape of the starting point illustrates the direction of how these ROIs load on Dimension 1 of PLSC (i.e., positive as square and negative as circle). The network labels illustrate where the means of the networks are for Controls.

As Dimension 1 differentiates participants with SSDs from Controls, to better illustrate the PLSC results of network hierarchy, we plotted the group differences of each ROI in Figures 3D3F (similar to Figures 2B2D) and highlighted those that contributed reliably (BR>2.88, p<.005).

Overall, this network hierarchy–cognition association, identified by the first dimension of PLSC, is driven by contributing ROIs, which also happened to show lower differentiation along all three gradients. For instance, PLSC identified ROIs from SMN, VIS2, DMN and Thalamus, which in SSDs showed lower differentiations on Gradient 1 (unimodal vs. multimodal networks). For Gradient 2 (visual vs. auditory networks), PLSC identified ROIs from CON, AUD, SMN, FPN, VIS2, and DAN, where the lower differentiations of SSDs were found mainly between different perceptual networks; more specifically, between AUD, SMN, FPN, CON and VIS2 with DAN. For Gradient 3 (default vs. frontoparietal networks), PLSC identified ROIs from the perceptual, language, and subcortical networks, where lower differentiations of SSDs were found between the unimodal networks (i.e., VIS and SMN) and LAN versus SUB. Interestingly, the identified ROIs of Gradient 3 from SMN, CON, and AUD networks were also those that were located close to LAN in the brain. This PLSC model is verified by 10-fold (rmin = .97) and 4-fold cross-validations (rmin = .94) (see Supplementary Materials for further details).

The first PLSC dimension is significantly related to functioning via both brain scores and cognitive scores

From the SSDs group, the correlation between the first latent variables (i.e., the behavior and the brain scores) and the clinical assessments of functioning or symptoms are illustrated in Figure 4. Figure 4A shows that, for Dimension 1, the cognitive scores are negatively correlated with the total score of BSFS (r=−.19, df=247, CI=[−.31, −.07], q=.003) and total scores of QLS (r=−.33, df=245, CI=[−.44, −.22], q<.0001), positively correlated with the SANS total score (r=.23, df=245, CI=[.11, .35], q=.0004), but have no significant correlation with symptoms on the BPRS total score (r=.12, df=247, CI=[−.0002, .25], q=.0576). These correlations remained significant after controlling for CPZ dosage equivalent (Table S3).

Figure 4. Correlations between cognitive and brain scores and clinical and functioning outcomes.

Figure 4.

A shows the scatter plot between the latent variable pair and the total scores of the clinical and functioning measures with correlation lines illustrating the linear relationships. Blue lines indicate significantly negative correlations and red lines indicate significantly positive correlations. B shows the squared correlation between the latent variable pair, brain scores (colored in purple) and cognitive scores (colored in dark green), and the subscales in the Birchwood Social Functioning Scale (BSFS; colored in black), the Quality of Life Scale (QLS; colored in pink), the Brief Psychiatric Rating Scale (BPRS; colored in green), and the Scale of the Assessment of Negative Symptoms (SANS; colored in cyan). The blue circles indicate positive correlations, and the red circles indicate negative correlations. The shaded area marks the magnitude of squared coefficients of correlation that are not significant in the Pearson correlation test.

Similarly, the brain scores of this dimension are negatively correlated with functioning, including the BSFS (r=−.25, df=247, CI=[−.36, −.13], q=.0003) and QLS (r=−.28, df=245, CI=[−.39, −.16], q<.0001, two missing values) total scores. However, these brain scores are positively correlated only with the SANS total score (r=.24, df=245, CI=[.12, .36], q=.0002), but not general psychopathology as measured by the BPRS total score (r=.11, df=247, CI=[−.01, .24], q=.0744). Correlation results with individual subscales are detailed in Table 3 and Figure 4B.

Table 3. Correlation between latent variables and clinical and functioning subscales.

The table shows how cognitive scores and brain scores correlate with the individual subscales of the Birchwood Social Functioning Scale (BSFS), the Quality of Life Scale (QLS), and two scales of symptoms, the Brief Psychiatric Rating Scale (BPRS) and the Scale of the Assessment of Negative Symptoms (SANS). The coefficients of correlation are reported along with their 95% confidence intervals (CI), and q(FDR) shows the FDR-corrected p-value for all 38 correlation tests. In these correlation tests, QLS intrapsychic foundations, QLS common objects and activities, and SANS avolition/apathy have 1 missing value. SANS asociality/anhedonia have 2 missing values.

Correlation with Cognitive Scores Correlation with Brain Scores

r [95% CI] q(FDR) r [95% CI] q(FDR)

Birchwood Social Functioning Scale (BSFS)
Social engagement/withdrawn .02 [−.11, .14] .832 −.02 [−.15, .10] .802
Interpersonal communication/relationship −.05 [−.18, .07] .478 −.10 [−.22, .03] .179
Interpersonal prosocial activity subscale −.08 [−.20, .05] .289 −.15 [−.27, −.03] .030
Recreation activity −.20 [−.32, −.08] .004 −.24 [−.36, −.12] .001
Independence performance −.14 [−.26, −.02] .045 −.15 [−.27, −.02] .035
Independence competence −.23 [−.34, −.10] .001 −.10 [−.22, .03] .179
Quality of Life Scale (QLS)
Interpersonal behavior −.25 [−.36, −.13] .001 −.20 [−.32, −.08] .004
Instrumental role −.27 [−.38, −.15] < .001 −.24 [−.35, −.12] .001
Intrapsychic foundations −.28 [−.39, −.16] < .001 −.22 [−.34, −.10] .001
Common objects and activities −.32 [−.43, −.21] < .001 −.28 [−.39, −.16] < .001
Brief Psychiatric Rating Scale (BPRS)
Negative symptoms .15 [.03, .27] .032 .09 [−.04, .21] .237
Positive symptoms .18 [.05, .30] .012 .07 [−.06, .19] .355
Anxiety/depression −.06 [−.18, .07] .429 .10 [−.02, .22] .167
Activation 0 [−.13, .12] .946 .01 [−.11, .14] .893
Hostility .12 [−.01, .24] .100 .02 [−.10, .15] .802
Scale for the Assessment of Negative Symptoms (SANS)
Affective flattening or blunting .15 [.03, .27] .030 .14 [.02, .26] .045
Alogia .33 [.21, .44] < .001 .21 [.08, .32] .004
Avolition/apathy .16 [.03, .28] .030 .19 [.07, .31] .006
Asociality/anhedonia .12 [−.01, .24] .098 .19 [.07, .31] .006

QLS intrapsychic foundations, QLS common objects and activities, and SANS avolition/apathy have 1 missing value. SANS asociality/anhedonia have 2 missing values.

Discussion

This study examined gradients from the resting-state functional connectivity of SSDs and Controls, using PLSC to explore multivariate associations with social and non-social cognition. Gradients offer an advantage of prior work focused on functional connectivity strength, as the gradient analysis considers topographical properties of how the brain networks are organized (e.g., in terms of well or poor segregation between unimodal and multimodal networks) with strong consensus among researchers on the interpretation of the extracted gradient dimensions (68). With a well-powered sample, we successfully replicated prior findings of unimodal-multimodal (Gradient 1) (1,16,17) and visual-sensorimotor (Gradient 2) (18) gradient compressions in SSDs and extended those findings via a compression of Gradient 3 between different multimodal networks. The PLSC results revealed the association between compressions along three gradients and the group differences between SSDs and Controls in both social and non-social cognitive abilities; similar associations were found in separate PLSCs respectively on each group, suggesting that the results were not driven by SSDs (see Supplementary Materials and Figure S8). Finally, in the SSDs group, higher latent cognitive and brain scores from the identified brain-cognition dimension was found correlated with higher negative symptoms and lower functioning and quality of life. Overall, although the brain-cognition association was expected, our study, with rich brain, behavioral, and functioning data with advanced multivariate methods, identified specific network changes and included multiple aspects of social cognition, along with clinical and functional measures. Clinical and functional relevance of brain-cognitive associations in stable participants with SSDs further suggest their role in the psychopathology and functioning of SSDs.

In contrast to previous gradient studies in SSDs (1,17,18), we included a broad assessment of social cognitive measures and examined multivariate associations with network organization. Although PLSC does not differentiate social from non-social cognition in brain-behavioral associations, the results were not a surprise as non-social and social cognitive performance are correlated and depend on overlapping networks (2,28). Our study showed that the differences in general cognitive ability between participants with SSDs and Controls are most related to the compression between the networks of vision (VIS1 and VIS2) and CON, along with other sensory modalities (AUD and SMN). These results are similar to Dong et al. (1) and Holmes et al. (18) and could be related to atypical connectivity especially in the visual and auditory networks (63), which give rise to positive symptoms or changes in cognition (64). Furthermore, from Dimension 1 of our PLSC, we identified associations between cognition and lower distinctions of two other areas: 1) between striatum and LAN on Gradient 3 and 2) between thalamus and unimodal networks on Gradient 1. These findings are consistent with stronger thalamic-sensorimotor connectivity in SSD than Controls in previous literature (6567) and aligned with previous literature that demonstrated the relationships between abnormal thalamic connectivity and sensory abnormalities (68,69). Together, these results support the hypothesis proposed by Andreasen et al. (70) that the dysfunction of the cortical-subcortical-cerebellar circuit (with thalamus being one of the main nodes) contributes to symptoms and cognitive deficits in SSDs. In addition, the contributing subcortical ROIs identified on Gradient 3 include caudate and nucleus accumbens, of which the connectivity to cortical regions were also found associated with improving psychosis after treatments for participants with first-episode SSDs (27).

Similar gradient compression has been shown in other populations and disorders, such as aging (71), sleep deprivation (72), usage of lysergic acid diethylamide (49), and to other psychiatric disorders, such as major depressive disorder (18) and autism spectrum disorder (ASD; 75). With similar cognitive challenges, SSDs and autism feature similar gradient compression, but different regions affected were found, which may relate to the difference between their symptom manifestation and onset time. Specifically for autism, another heterogenous disorder, Choi et al. (75) showed that only the most severe of three delineated subgroups featured gradient compression. Similar compression to SSDs was found in autism for sensorimotor regions, anterior cingulate cortex (ACC), visual cortex, and right inferior temporal cortex (ITC), where ACC and ITC were associated with semantic control and social cognition (15). Their study found compression in autism in the posterior cingulate cortex but not in the auditory network, which was found in our study, suggesting that disorder-specific functional brain organizations could exist.

Previous studies have shown the alignment between principal gradients and human microstructural gradients of brain regions and the T1/T2 myelination map (68). A significant proportion of gene sets that show differential expression across the myelination map are also shown associated with SSDs (76). As a result, the identified gradient compression of SSDs could be related to myelin abnormalities. As SSDs tend to present clinically while myelination is in progress, a “demyelination hypothesis” of SSDs has been proposed (77). Recently, lower cortical myelination has been found in people with SSDs (77,78) encompassing inferior longitudinal fasciculus (ILF) and superior longitudinal fasciculus (SLF) (78). Between them, ILF connects temporal and occipital cortices, which align with the two ends of the visual-sensorimotor gradient, and SLF connects frontal and occipital cortices, which align with the two ends of the unimodal-multimodal gradient. Therefore, the observed visual-sensorimotor and unimodal-multimodal gradient compressions could be related to the disruption of myelination in these white matter tracts, ILF and SLF respectively, which connect those networks.

Limitations

These results provide insights into the network mechanisms of SSDs but may be influenced by sample characteristics. Participants with SSDs were on stable antipsychotic treatment, which might affect the observed lack of correlation between network compression and positive symptoms. While antipsychotic medication is known to impact brain structure (79), its effect on gradients is unclear—we regressed out CPZ equivalents to address this issue. Although our study focused on SSDs, the findings might relate to general mental health risks, supporting the need for transdiagnostic research. Furthermore, though site and motion effects were present in our data, they were mitigated using harmonization by statistical regression, and preprocessing workflows and quality checks, respectively. Additional considerations include the lower signal-to-noise ratio of 7-minute resting-state scans, potential noise from using brain atlases derived from healthy participants (80), and the debated impact of global signal removal. Finally, as gradient analysis provides one of many multivariate frameworks to decompose and interpret functional connectivity, other multivariate frameworks could yield varied results.

Conclusion

Most prior studies on connectivity in SSDs and cognition focused on the strength of specific connections (37,66,81). Gradient analysis, however, reveals broader changes in network organization (3,71). We found that reduced network segregation is linked to psychopathology and poorer social and non-social cognition, predicting functional outcomes. This suggests that cognitive deficits in SSDs stem not only from reduced connectivity but also from disrupted network organization and segregation. The correlations between gradients, clinical symptoms, and functional outcomes highlight the clinical relevance of these findings. These insights may help identify prognostic markers and potential treatment targets for SSDs.

Supplementary Material

1

Acknowledgement

The authors would like to thank all participants for their contribution to this work, and the research staff who performed data collection and management. This work was supported by National Institute of Mental Health grants 1/3R01MH102324-01 (to Dr. Voineskos), 2/3R01MH102313-01 (to Dr. Malhotra), and 3/3R01MH102318-01 (to Dr. Buchanan) as well as support from the Discovery Fund of the Centre for Addiction and Mental Health (CAMH) and the Canadian Institutes of Health Research (CIHR).

Financial Disclosures

Dr. Yu receives grant support from the Discovery Fund of the Centre for Addiction and Mental Health (CAMH). Dr. Hawco receives grant support from the National Institute of Mental Health (NIMH), Canadian Institutes of Health Research (CIHR), and the Centre for Addiction and Mental Health (CAMH) Foundation. Ms. Bassman reported no biomedical financial interests or potential conflicts of interest. Dr. Oliver receives grant support from the Brain & Behavior Research Foundation (BBRF). Dr. Argyelan reported no biomedical financial interests or potential conflicts of interest. Dr. Gold reported no biomedical financial interests or potential conflicts of interest. Dr. Tang receives grant support from the NIMH (K23 MH130750, R21 AG082054), she also owns equity and serves as a consultant for North Shore Therapeutics, received research funding and serves as a consultant for Winterlight Labs, and is on the advisory board and owns equity for Psyrin. Dr. Foussias currently receives funding from CIHR, the CAMH Foundation, and the University of Toronto. Dr. Buchanan has consulted for Boehringer-Ingelheim, serves on the Data Safety and Monitoring Boards of Roche, Merck, and Newron, and has served on the Advisory Boards of Merck, Acadia, Karuna, and Neurocrine. Dr. Malhotra receives grant support from the NIMH (R01 MH109508, R01 MH108654, R61 MH120188). Dr. Ameis currently receives funding from the NIMH (R01 MH114879), CIHR, University of Toronto, and the CAMH Foundation. Dr. Voineskos currently receives funding from the NIMH (1/3R01 MH102324, 1/5R01 MH114970), CIHR, Canada Foundation for Innovation, CAMH Foundation, and University of Toronto. Dr. Dickie has received funding from BBRF, NIMH, CIHR, and CAMH Foundation. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Dong D, Yao D, Wang Y, Hong S-J, Genon S, Xin F, et al. (2021): Compressed sensorimotor-to-transmodal hierarchical organization in schizophrenia. Psychol Med 1–14. [DOI] [PubMed] [Google Scholar]
  • 2.Oliver LD, Hawco C, Homan P, Lee J, Green MF, Gold JM, et al. (2021): Social Cognitive Networks and Social Cognitive Performance Across Individuals With Schizophrenia Spectrum Disorders and Healthy Control Participants. Biol Psychiatry Cogn Neurosci Neuroimaging 6: 1202–1214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Margulies DS, Ghosh SS, Goulas A, Falkiewicz M, Huntenburg JM, Langs G, et al. (2016): Situating the default-mode network along a principal gradient of macroscale cortical organization. Proc Natl Acad Sci 113: 12574–12579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Park H-J, Friston K (2013): Structural and Functional Brain Networks: From Connections to Cognition. Science 342: 1238411. [DOI] [PubMed] [Google Scholar]
  • 5.Pang JC, Aquino KM, Oldehinkel M, Robinson PA, Fulcher BD, Breakspear M, Fornito A (2023): Geometric constraints on human brain function. Nature 618: 566–574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Huntenburg JM, Bazin P-L, Goulas A, Tardif CL, Villringer A, Margulies DS (2017): A Systematic Relationship Between Functional Connectivity and Intracortical Myelin in the Human Cerebral Cortex. Cereb Cortex 27: 981–997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Huntenburg JM, Bazin P-L, Margulies DS (2018): Large-Scale Gradients in Human Cortical Organization. Trends Cogn Sci 22: 21–31. [DOI] [PubMed] [Google Scholar]
  • 8.Blazquez Freches G, Haak KV, Bryant KL, Schurz M, Beckmann CF, Mars RB (2020): Principles of temporal association cortex organisation as revealed by connectivity gradients. Brain Struct Funct 225: 1245–1260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dong H-M, Margulies DS, Zuo X-N, Holmes AJ (2021): Shifting gradients of macroscale cortical organization mark the transition from childhood to adolescence. Proc Natl Acad Sci 118: e2024448118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Xia Y, Xia M, Liu J, Liao X, Lei T, Liang X, et al. (2022): Development of functional connectome gradients during childhood and adolescence. Sci Bull 67: 1049–1061. [DOI] [PubMed] [Google Scholar]
  • 11.Froudist-Walsh S, Xu T, Niu M, Rapan L, Zhao L, Margulies DS, et al. (2023): Gradients of neurotransmitter receptor expression in the macaque cortex. Nat Neurosci 26: 1281–1294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Huo T, Xia Y, Zhuang K, Chen Q, Sun J, Yang W, Qiu J (2022): Linking functional connectome gradient to individual creativity. Cereb Cortex N Y N 1991 bhac013. [DOI] [PubMed] [Google Scholar]
  • 13.Gao Z, Zheng L, Krieger-Redwood K, Halai A, Margulies DS, Smallwood J, Jefferies E (2022): Flexing the principal gradient of the cerebral cortex to suit changing semantic task demands. eLife 11: e80368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gonzalez Alam TRDJ, Mckeown BLA, Gao Z, Bernhardt B, Vos De Wael R, Margulies DS, et al. (2022): A tale of two gradients: differences between the left and right hemispheres predict semantic cognition. Brain Struct Funct 227: 631–654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Diveica V, Koldewyn K, Binney RJ (2021): Establishing a role of the semantic control network in social cognitive processing: A meta-analysis of functional neuroimaging studies. NeuroImage 245: 118702. [DOI] [PubMed] [Google Scholar]
  • 16.Dong D, Luo C, Guell X, Wang Y, He H, Duan M, et al. (2020): Compression of Cerebellar Functional Gradients in Schizophrenia. Schizophr Bull 46: 1282–1295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Wang M, Li A, Liu Y, Yan H, Sun Y, Song M, et al. (2020): Reproducible Abnormalities of Functional Gradient Reliably Predict Clinical and Cognitive Symptoms in Schizophrenia. BioRxiv, 2020-11. 10.1101/2020.11.24.395251 [DOI] [Google Scholar]
  • 18.Holmes A, Levi PT, Chen Y-C, Chopra S, Aquino KM, Pang JC, Fornito A (2023): Disruptions of Hierarchical Cortical Organization in Early Psychosis and Schizophrenia. Biol Psychiatry Cogn Neurosci Neuroimaging S2451902223002203. [DOI] [PubMed] [Google Scholar]
  • 19.Tsuang MT, Lyons MJ, Faraone SV (1990): Heterogeneity of Schizophrenia: Conceptual Models and Analytic Strategies. Br J Psychiatry 156: 17–26. [DOI] [PubMed] [Google Scholar]
  • 20.Conley RR, Kelly DL (2001): Management of treatment resistance in schizophrenia. Biol Psychiatry 50: 898–911. [DOI] [PubMed] [Google Scholar]
  • 21.Leucht S, Cipriani A, Spineli L, Mavridis D, Örey D, Richter F, et al. (2013): Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. The Lancet 382: 951–962. [DOI] [PubMed] [Google Scholar]
  • 22.Goldstein G, Allen DN, Van Kammen DP (1998): Individual Differences in Cognitive Decline in Schizophrenia. Am J Psychiatry 155: 1117–1118. [DOI] [PubMed] [Google Scholar]
  • 23.Van Rheenen TE, Lewandowski KE, Tan EJ, Ospina LH, Ongur D, Neill E, et al. (2017): Characterizing cognitive heterogeneity on the schizophrenia–bipolar disorder spectrum. Psychol Med 47: 1848–1864. [DOI] [PubMed] [Google Scholar]
  • 24.Gallucci J, Pomarol-Clotet E, Voineskos AN, Guerrero-Pedraza A, Alonso-Lana S, Vieta E, et al. (2022): Longer illness duration is associated with greater individual variability in functional brain activity in Schizophrenia, but not bipolar disorder. NeuroImage Clin 36: 103269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Gallucci J, Tan T, Schifani C, Dickie EW, Voineskos AN, Hawco C (2022): Greater individual variability in functional brain activity during working memory performance in Schizophrenia Spectrum Disorders (SSD). Schizophr Res 248: 21–31. [DOI] [PubMed] [Google Scholar]
  • 26.Hawco C, Buchanan RW, Calarco N, Mulsant BH, Viviano JD, Dickie EW, et al. (2019): Separable and Replicable Neural Strategies During Social Brain Function in People With and Without Severe Mental Illness. Am J Psychiatry 176: 521–530. [DOI] [PubMed] [Google Scholar]
  • 27.Sarpal DK, Robinson DG, Lencz T, Argyelan M, Ikuta T, Karlsgodt K, et al. (2015): Antipsychotic Treatment and Functional Connectivity of the Striatum in First-Episode Schizophrenia. JAMA Psychiatry 72: 5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Fett A-KJ, Viechtbauer W, Dominguez M-G, Penn DL, Van Os J, Krabbendam L (2011): The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis. Neurosci Biobehav Rev 35: 573–588. [DOI] [PubMed] [Google Scholar]
  • 29.Couture SM (2006): The Functional Significance of Social Cognition in Schizophrenia: A Review. Schizophr Bull 32: S44–S63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Green MF, Kern RS, Heaton RK (2004): Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 72: 41–51. [DOI] [PubMed] [Google Scholar]
  • 31.Green MF, Horan WP, Lee J (2019): Nonsocial and social cognition in schizophrenia: current evidence and future directions. World Psychiatry 18: 146–161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mier D, Eisenacher S, Rausch F, Englisch S, Gerchen MF, Zamoscik V, et al. (2017): Aberrant activity and connectivity of the posterior superior temporal sulcus during social cognition in schizophrenia. Eur Arch Psychiatry Clin Neurosci 267: 597–610. [DOI] [PubMed] [Google Scholar]
  • 33.Green MF, Horan WP, Lee J (2015): Social cognition in schizophrenia. Nat Rev Neurosci 16: 620–631. [DOI] [PubMed] [Google Scholar]
  • 34.Friston KJ, Frith CD (1995): Schizophrenia: a disconnection syndrome. Clin Neurosci 3: 89–97. [PubMed] [Google Scholar]
  • 35.Choe E, Lee TY, Kim M, Hur J-W, Yoon YB, Cho K-IK, Kwon JS (2018): Aberrant within- and between-network connectivity of the mirror neuron system network and the mentalizing network in first episode psychosis. Schizophr Res 199: 243–249. [DOI] [PubMed] [Google Scholar]
  • 36.Argyelan M, Gallego JA, Robinson DG, Ikuta T, Sarpal D, John M, et al. (2015): Abnormal Resting State fMRI Activity Predicts Processing Speed Deficits in First-Episode Psychosis. Neuropsychopharmacology 40: 1631–1639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Viviano JD, Buchanan RW, Calarco N, Gold JM, Foussias G, Bhagwat N, et al. (2018): Resting-State Connectivity Biomarkers of Cognitive Performance and Social Function in Individuals With Schizophrenia Spectrum Disorder and Healthy Control Subjects. Biol Psychiatry 84: 665–674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Leucht S, Samara M, Heres S, Davis JM (2016): Dose Equivalents for Antipsychotic Drugs: The DDD Method. Schizophr Bull 42: S90–S94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Wechsler D (2001): Wechsler Test of Adult Reading: WTAR. Psychological Corporation. [Google Scholar]
  • 40.Overall JE, Gorham DR (1962): The Brief Psychiatric Rating Scale. Psychol Rep 10: 799–812. [Google Scholar]
  • 41.Andreasen NC (1982): Negative Symptoms in Schizophrenia: Definition and Reliability. Arch Gen Psychiatry 39: 784. [DOI] [PubMed] [Google Scholar]
  • 42.Buchanan RW, Javitt DC, Marder SR, Schooler NR, Gold JM, McMahon RP, et al. (2007): The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): The Efficacy of Glutamatergic Agents for Negative Symptoms and Cognitive Impairments. Am J Psychiatry 164: 1593–1602. [DOI] [PubMed] [Google Scholar]
  • 43.Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S (1990): The Social Functioning Scale the Development and Validation of a New Scale of Social Adjustment for use in Family Intervention Programmes with Schizophrenic Patients. Br J Psychiatry 157: 853–859. [DOI] [PubMed] [Google Scholar]
  • 44.Heinrichs DW, Hanlon TE, Carpenter WT (1984): The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit Syndrome. Schizophr Bull 10: 388–398. [DOI] [PubMed] [Google Scholar]
  • 45.Oliver LD, Haltigan JD, Gold JM, Foussias G, DeRosse P, Buchanan RW, et al. (2019): Lower- and Higher-Level Social Cognitive Factors Across Individuals With Schizophrenia Spectrum Disorders and Healthy Controls: Relationship With Neurocognition and Functional Outcome. Schizophr Bull 45: 629–638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, et al. (2008): The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity. Am J Psychiatry 165: 203–213. [DOI] [PubMed] [Google Scholar]
  • 47.Kohler CG, Bilker W, Hagendoorn M, Gur RE, Gur RC (2000): Emotion recognition deficit in schizophrenia: association with symptomatology and cognition. Biol Psychiatry 48: 127–136. [DOI] [PubMed] [Google Scholar]
  • 48.Baron-Cohen S, Wheelwright S, Hill J, Raste Y, Plumb I (2001): The “Reading the Mind in the Eyes” Test Revised Version: A Study with Normal Adults, and Adults with Asperger Syndrome or High-functioning Autism. J Child Psychol Psychiatry 42: 241–251. [PubMed] [Google Scholar]
  • 49.McDonald S, Flanagan S, Rollins J (2011): The awareness of social inference test (revised). New South Wales Aust Australas Soc Study Brain Impair. [Google Scholar]
  • 50.Esteban O, Markiewicz CJ, Blair RW, Moodie CA, Isik AI, Erramuzpe A, et al. (2019): fMRIPrep: a robust preprocessing pipeline for functional MRI. Nat Methods 16: 111–116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Dickie EW, Anticevic A, Smith DE, Coalson TS, Manogaran M, Calarco N, et al. (2019): Ciftify: A framework for surface-based analysis of legacy MR acquisitions. NeuroImage 197: 818–826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Glasser MF, Coalson TS, Robinson EC, Hacker CD, Harwell J, Yacoub E, et al. (2016): A multi-modal parcellation of human cerebral cortex. Nature 536: 171–178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Tian Y, Margulies DS, Breakspear M, Zalesky A (2020): Topographic organization of the human subcortex unveiled with functional connectivity gradients. Nat Neurosci 23: 1421–1432. [DOI] [PubMed] [Google Scholar]
  • 54.Ji JL, Spronk M, Kulkarni K, Repovš G, Anticevic A, Cole MW (2019): Mapping the human brain’s cortical-subcortical functional network organization. NeuroImage 185: 35–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Fortin J-P, Cullen N, Sheline YI, Taylor WD, Aselcioglu I, Cook PA, et al. (2018): Harmonization of cortical thickness measurements across scanners and sites. NeuroImage 167: 104–120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Johnson WE, Li C, Rabinovic A (2007): Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 118–127. [DOI] [PubMed] [Google Scholar]
  • 57.Coifman RR, Lafon S, Lee AB, Maggioni M, Nadler B, Warner F, Zucker SW (2005): Geometric diffusions as a tool for harmonic analysis and structure definition of data: Diffusion maps. Proc Natl Acad Sci 102: 7426–7431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Vos De Wael R, Benkarim O, Paquola C, Lariviere S, Royer J, Tavakol S, et al. (2020): BrainSpace: a toolbox for the analysis of macroscale gradients in neuroimaging and connectomics datasets. Commun Biol 3: 103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Krishnan A, Williams LJ, McIntosh AR, Abdi H (2011): Partial Least Squares (PLS) methods for neuroimaging: a tutorial and review. Neuroimage 56: 455–475. [DOI] [PubMed] [Google Scholar]
  • 60.Berry KJ, Johnston JE, Mielke PW (2011): Permutation methods. WIREs Comput Stat 3: 527–542. [Google Scholar]
  • 61.Hesterberg T (2011): Bootstrap. WIREs Comput Stat 3: 497–526. [Google Scholar]
  • 62.R Development Core Team (2010): R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Retrieved from http://www.R-project.org [Google Scholar]
  • 63.Hanlon FM, Shaff NA, Dodd AB, Ling JM, Bustillo JR, Abbott CC, et al. (2016): Hemodynamic response function abnormalities in schizophrenia during a multisensory detection task: Hemodynamic Response Function Abnormalities. Hum Brain Mapp 37: 745–755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Gröhn C, Norgren E, Eriksson L (2022): A systematic review of the neural correlates of multisensory integration in schizophrenia. Schizophr Res Cogn 27: 100219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Anticevic A, Cole MW, Repovs G, Murray JD, Brumbaugh MS, Winkler AM, et al. (2014): Characterizing Thalamo-Cortical Disturbances in Schizophrenia and Bipolar Illness. Cereb Cortex 24: 3116–3130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Damaraju E, Allen EA, Belger A, Ford JM, McEwen S, Mathalon DH, et al. (2014): Dynamic functional connectivity analysis reveals transient states of dysconnectivity in schizophrenia. NeuroImage Clin 5: 298–308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Woodward ND, Karbasforoushan H, Heckers S (2012): Thalamocortical Dysconnectivity in Schizophrenia. Am J Psychiatry 169: 1092–1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Abram SV, Hua JPY, Ford JM (2022): Consider the pons: bridging the gap on sensory prediction abnormalities in schizophrenia. Trends Neurosci 45: 798–808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Behrendt R-P, Young C (2004): Hallucinations in schizophrenia, sensory impairment, and brain disease: A unifying model. Behav Brain Sci 27: 771–787. [DOI] [PubMed] [Google Scholar]
  • 70.Andreasen NC, Paradiso S, O’Leary DS (1998): “Cognitive Dysmetria” as an Integrative Theory of Schizophrenia: A Dysfunction in Cortical-Subcortical-Cerebellar Circuitry? Schizophr Bull 24: 203–218. [DOI] [PubMed] [Google Scholar]
  • 71.Bethlehem RAI, Paquola C, Seidlitz J, Ronan L, Bernhardt B, Consortium C-C, Tsvetanov KA (2020): Dispersion of functional gradients across the adult lifespan. NeuroImage 222: 117299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Cross N, Paquola C, Pomares FB, Perrault AA, Jegou A, Nguyen A, et al. (2021): Cortical gradients of functional connectivity are robust to state-dependent changes following sleep deprivation. NeuroImage 226: 117547. [DOI] [PubMed] [Google Scholar]
  • 73.Girn M, Roseman L, Bernhardt B, Smallwood J, Carhart-Harris R, Nathan Spreng R (2022): Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex. NeuroImage 256: 119220. [DOI] [PubMed] [Google Scholar]
  • 74.Xia M, Liu J, Mechelli A, Sun X, Ma Q, Wang X, et al. (2022): Connectome gradient dysfunction in major depression and its association with gene expression profiles and treatment outcomes. Mol Psychiatry. 10.1038/s41380-022-01519-5 [DOI] [PubMed] [Google Scholar]
  • 75.Choi H, Byeon K, Park B, Lee J, Valk SL, Bernhardt B, et al. (2022): Diagnosis-informed connectivity subtyping discovers subgroups of autism with reproducible symptom profiles. NeuroImage 256: 119212. [DOI] [PubMed] [Google Scholar]
  • 76.Burt JB, Demirtaş M, Eckner WJ, Navejar NM, Ji JL, Martin WJ, et al. (2018): Hierarchy of transcriptomic specialization across human cortex captured by structural neuroimaging topography. Nat Neurosci 21: 1251–1259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Flynn SW, Lang DJ, Mackay AL, Goghari V, Vavasour IM, Whittall KP, et al. (2003): Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry 8: 811–820. [DOI] [PubMed] [Google Scholar]
  • 78.Vanes LD, Mouchlianitis E, Barry E, Patel K, Wong K, Shergill SS (2019): Cognitive correlates of abnormal myelination in psychosis. Sci Rep 9: 5162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Voineskos AN, Mulsant BH, Dickie EW, Neufeld NH, Rothschild AJ, Whyte EM, et al. (2020): Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial. JAMA Psychiatry 77: 674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Levi PT, Chopra S, Pang JC, Holmes A, Gajwani M, Sassenberg TA, et al. (2023): The effect of using group-averaged or individualized brain parcellations when investigating connectome dysfunction in psychosis. Netw Neurosci 7: 1228–1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Sarpal DK, Argyelan M, Robinson DG, Szeszko PR, Karlsgodt KH, John M, et al. (2016): Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment. Am J Psychiatry 173: 69–77. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES